Enhance MD vs Hers: Flat-Rate Compounds vs FDA-Approved Wegovy
Choosing between Enhance MD and Hers hinges on pricing model and medication type. Early verdict: Enhance MD is the lower-cost compounded option for users focused on first-month price and flat-rate dosing; Hers is the option for those who prefer FDA-approved Wegovy and a personalized care team.
See Enhance MD pricing and options
Head-to-head overview: Enhance MD vs Hers
This comparison uses only captured provider facts. Enhance MD advertises compounded semaglutide from $49 first month and compounded tirzepatide from $99 first month with flat-rate pricing that stays the same at every dose. Hers advertises FDA-approved Wegovy from $149/mo with a personalized care team and ongoing dose check-ins; medication requires an active Hers Weight Loss Membership.
Most distinctive differences
- Medication type: compounded medications (Enhance MD) vs FDA-approved brand Wegovy (Hers).
- Starting price structure: Enhance MD lists semaglutide from $49 first month; Hers lists Wegovy from $149/mo.
- Pricing model: Enhance MD emphasizes flat-rate pricing that does not escalate with dose; Hers requires a membership fee and bills medication and membership separately.
- Care model and offerings: Hers highlights a personalized care team and ongoing dose check-ins; Enhance MD highlights availability of both semaglutide and tirzepatide on one platform and clinician-directed review.
- Regulatory note: Both sources state compounded medications are not FDA-approved where applicable; Hers promotes FDA-approved brand-name options.
Side-by-side comparison table
| Criteria | Enhance MD | Hers |
|---|---|---|
| Medication type | Compounded semaglutide and tirzepatide; compounded medications not FDA-approved | FDA-approved Wegovy (brand-name semaglutide); no compounded medications |
| Starting price | Semaglutide starting at $49 first month; tirzepatide from $99 first month | Wegovy from $149/mo (membership required; medication billed separately) |
| Pricing model | Flat-rate pricing: same price at every dose, no escalation during titration | Membership + medication billed separately; membership required for medication access |
| Care features | Clinician-directed review; treated 10,000+ patients as reported | Personalized care team with ongoing dose check-ins |
| Availability notes | Direct-pay platform; does not bill insurance; compounds offered | Not available in all 50 states; prescription and eligibility determined by clinician |
Pricing and payment structure comparison
Enhance MD promotes a very low first-month entry point for compounded products: semaglutide from $49 and tirzepatide from $99 for the first month, and emphasizes that after introductory pricing a flat-rate applies so price does not increase with higher doses. Hers presents Wegovy from $149/mo but states an active Hers Weight Loss Membership is required; medication cost and membership fees are billed separately and membership is required for medication access.
Check Enhance MD first-month pricing
Medication type and regulatory notes
Enhance MD supplies compounded semaglutide and compounded tirzepatide and explicitly notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Hers emphasizes FDA-approved Wegovy as a brand-name semaglutide option and confirms it does not offer compounded medications.
Care experience and platform features
Enhance MD highlights clinician-directed compounds and reports a real-world patient volume of 10,000+ treated patients. Hers emphasizes a personalized care team with ongoing dose check-ins and promotes doctor-trusted FDA-approved GLP-1 options. Hers also notes membership terms, state availability limits, and that a prescription is not guaranteed.
Explore Hers Wegovy and membership details
How to decide: key trade-offs
Choose based on whether the priority is lower first-month cost and flat-rate compounded options, or FDA-approved brand-name medication with a care team. If you must have an FDA-approved brand, Hers documents Wegovy availability and team-based dose check-ins. If entry cost and flat-rate dose pricing matter most, Enhance MD reports the lowest first-month prices for both semaglutide and tirzepatide and flat-rate ongoing pricing.
Start with Enhance MD pricing and details
Final thoughts on Enhance MD vs Hers
Enhance MD vs Hers centers on compounded, low-entry pricing with flat-rate dosing versus FDA-approved Wegovy with a membership and personalized care. The primary keyword Enhance MD vs Hers captures that choice: Enhance MD for low first-month compounded options and flat-rate dosing; Hers for FDA-approved Wegovy and a care team with ongoing check-ins.
Choose Enhance MD if…
- You want compounded semaglutide from $49 first month or compounded tirzepatide from $99 first month and a flat-rate pricing model that stays the same at every dose.
Choose Hers if…
- You prefer FDA-approved Wegovy (brand-name semaglutide), want a personalized care team with ongoing dose check-ins, and accept that medication access requires an active membership.